United States
Print page content Print
Increase text size Decrease text size
Text Size

Effective in Helping Prevent PCV2 Viremia

  • No acute abnormalities were attributable to the use of
    Fostera® PCV MH
  • Observations of abnormalities post-vaccination were the same or fewer in vaccinated pigs than in controls

  Read the Efficacy Technical Bulletin

1. Data on file, Study Report No. B921R-US-12-009, Zoetis Inc.

  • Abnormal health events were consistent with herd health observations and not related to administration of Fostera® PCV MH
  • Injection site reactions were mild and quickly resolved

  Read the Efficacy Technical Bulletin

2. Data on file, Study Report No. B822R-US-12-111, Zoetis Inc.